• Make it like cafepharma, but for different industries: over the years we’ve had suggestions for creating a site similar to cafepharma, but for different industries. Now there is a place. Check out CompanyUnderground for company forums in other industries. Don’t see a company? Request it here. Let your friends and family outside the pharma/medical sales space know they now have a safe, anonymous place to talk.


THIS COMPANY IS DOOMED

Quote












The Genentechnocrats have been unable to break the Roche infected code that was used to brainwash our leadership. And now we have all become infected.

Is there no road to salvation for any of us ? Call Boxer or Feinstein. They owe us big time people. Time to collect on their legislative debts.
 






Good Luck! I got laid off (from Roche/Genen), took a pay cut & went to small pharma. Limited meetings/teleconferences/field days. They let us work and make calls: Amazing. I sleep better at night and enjoy everything better. i wish the best for you all. The waiting is killing the company. Good Luck to all!
 
























You don't know the half of it. Say what you want about Roche but they had history knowledge and a sense of making mistakes in the past but learning from them. Of course they were all laid off or told they did not fit. Now you are starting with green cocky dim bulbs who think their drugs sell themselves. This will be painful. I still miss working for Roche but not Genentech.
 






Anonymous said:
All we do anymore is have conference calls about nothing and go to meeting about nothing, and nothing gets done in the field. Roche, it's where companys go to die.
Click to expand...

Roche never had CC's and meeting before we OWNED you punks. This is a Genentech thing created by Genentech management. Everyone is trying to show how important they and their job are. The days of Genetech job glutoney are over. SSF payroll could be cut in half and more would get done.

Roche made a grave mistake buy Genentech without slashing all the fat and redundancy in Goobertown.
 












You are correct. Genentech was on the way down prior to Roche. It all started when the GSK and Novartis folks came in with their values (protect yourself). When people like GS in Managed Care were hired as Director of Sales for Rituxan, you had to know there were idiots at the top. The entrance of Roche has simply made the process move faster. Glad I got out when I did with the big check. Not making as much money now but not putting up with the BS of Ian either. All the "YES" men that are in place now will be the last to get cut.
 






Anonymous said:
You are correct. Genentech was on the way down prior to Roche. It all started when the GSK and Novartis folks came in with their values (protect yourself). When people like GS in Managed Care were hired as Director of Sales for Rituxan, you had to know there were idiots at the top. The entrance of Roche has simply made the process move faster. Glad I got out when I did with the big check. Not making as much money now but not putting up with the BS of Ian either. All the "YES" men that are in place now will be the last to get cut.
Click to expand...

Ian was the the novartis/roche spy that started everything going down the road to failureville, but nobody can do failure like roche does failure. The people who made DNA sucessful are all gone.
 






are you a*holes kidding. Genentech was a great company before Roche??????

Is there NO realization that you guys had a product that sold itself - kind of like being the best ice salesperson in florida, they would buy it anyway but if you have big t*ts it aint going to hurt.

Roche has a Looooooong history of great products. Genentech has a short history of great products. For both companies when your patent runs out you find other options. For Roche it was to buy all of Genentech, for Genentech it was to..... get bought.

For the leaders of GNE that was a great step, for you other morons, not so much.


hahahahahahhahahahaha
 






I agree. I'm so tired of hearing the "legacy" Genentech folks dissing Roche. One thing they forget is there is a point in a companies growth when it no longer fits the small pharma model and becomes BIG pharma. That is where Genentech was headed when Roche acquired it so the company was going to change (and was changing) no matter if it was acquired or not.
 






Anonymous said:
are you a*holes kidding. Genentech was a great company before Roche??????

Is there NO realization that you guys had a product that sold itself - kind of like being the best ice salesperson in florida, they would buy it anyway but if you have big t*ts it aint going to hurt.

Roche has a Looooooong history of great products. Genentech has a short history of great products. For both companies when your patent runs out you find other options. For Roche it was to buy all of Genentech, for Genentech it was to..... get bought.

For the leaders of GNE that was a great step, for you other morons, not so much.


hahahahahahhahahahaha
Click to expand...
They also fail to realize that there would have been NO Genentech, without Roche money. Despite the fact that they remained an independant company, as far back as September of 1990 Roche owned more than 100% of the economic and voting shares of Genentech. They Roche sold a small amount of Genentech stock in 1995, then again in 1999, and 2000. They sold a lot of the stock in 1999 and 2000 and made huge profits due to the explosion of the Genentech share price.

These are the facts, Roche has owned Genentech since 1990, owning from 100% to 51% of the economic and voting stock. So you see, the only thing that Genentech discovered and commercialized on its own, while not being wholly owned by Roche is Nutropin. Every drug that was researched, developed, or commercialized since 1990 was done as a Roche owned, but independently operated company, and on Roche's dime; That includes Avastin, etc.

So legacy Roche folks, dont fall into the "US" vs. "them" rhetoric. Without "our" money "they" would not achieved anything. The fact is that "they" were always "US". For those superior "Genentechians", our little brothers, that doubt what I am seeing, please read the three links below, 2 of which come directly from the Genentech website. KNOW YOUR HISTORY!

http://www.gene.com/gene/news/press-releases/display.do?method=print&id=4894
http://articles.latimes.com/1999/jun/04/business/fi-44003
http://www.gene.com/gene/about/ir/historical/stock-info.html
 






Anonymous said:
They also fail to realize that there would have been NO Genentech, without Roche money. Despite the fact that they remained an independant company, as far back as September of 1990 Roche owned more than 100% of the economic and voting shares of Genentech. They Roche sold a small amount of Genentech stock in 1995, then again in 1999, and 2000. They sold a lot of the stock in 1999 and 2000 and made huge profits due to the explosion of the Genentech share price.

These are the facts, Roche has owned Genentech since 1990, owning from 100% to 51% of the economic and voting stock. So you see, the only thing that Genentech discovered and commercialized on its own, while not being wholly owned by Roche is Nutropin. Every drug that was researched, developed, or commercialized since 1990 was done as a Roche owned, but independently operated company, and on Roche's dime; That includes Avastin, etc.

So legacy Roche folks, dont fall into the "US" vs. "them" rhetoric. Without "our" money "they" would not achieved anything. The fact is that "they" were always "US". For those superior "Genentechians", our little brothers, that doubt what I am seeing, please read the three links below, 2 of which come directly from the Genentech website. KNOW YOUR HISTORY!

http://www.gene.com/gene/news/press-releases/display.do?method=print&id=4894
http://articles.latimes.com/1999/jun/04/business/fi-44003
http://www.gene.com/gene/about/ir/historical/stock-info.html
Click to expand...

Great and so what..the truth is the legacy Roche days are numbered. We developed Genentech, We owned Genentech, we bought Genentech, and now they are getting rid of us. Just ask a Roche primary care rep, or Onc, or Rheum, or George, or Dick.
 






Anonymous said:
Great and so what..the truth is the legacy Roche days are numbered. We developed Genentech, We owned Genentech, we bought Genentech, and now they are getting rid of us. Just ask a Roche primary care rep, or Onc, or Rheum, or George, or Dick.
Click to expand...

There is no "THEY", they are "US". There is no conspiracy, PRIMARY CARE got devastated ONLY because Taspoglutide got pulled, and Boniva is in a market that is almost 80% generic, and is going off patent next April. The bottomline is that based on the market conditions, there should have been a big cut years ago. The anticipation of Taspo is all that prevented this. For example, for two years MCR reps were carried when they really had no product to sell. They should have been fired 3 years ago. There are some great products in the pipeline, and if those products come to fruition, primary care will be expanded.

First off, I am Legacy PC. As far as george is concerned, he was offered a job in the new organization, and he decided not to accept it. Besides, he was not terminated by some "legacy" Genentech manager, he was fired by basel based executive management. As far as dick goes, he was highly ineffective. He was in charge of a franchise that was dramatically underperforming. If you loved him so much, you should have "sold" more boniva. The problem with Tim and George is that the were too squeamish too make critical BUSINESS decisions. I use the MCRs as one example, from a business perspective, ALL MCR positions should have been eliminated more than three years ago, yet they were kept. The fact that you had 7 regional offices, each with their own sales ops, etc was also highly inefficient. Lastly resource allocation among the regions was pretty stupid. For example, all budgets, samples, etc were pretty much divided evenly among the seven regions, even though the business opportunities were heavily concentrated among 2-3 regions. The resources shoiuld have been divided in proportion to where the business was. The fact that the sales force is doing so well, now, with 75% fewer reps in proof positive that the sales force was waaaay to large, and should have been slashed years ago. And if there is no new product to sell by the end of the year, it is perfectly rational, and fiduciarily responsible for management to fire the rest of PC.

As far as oncology goes, both legacy forces have lost people, and as far as rheum goes, well Actemra is a DOG! My suggestion is that you stop thinking of yourself as a victim, and look at the business side of decisons, instead of the "THEY DONT LIKE US" side. No company is going to make decisions that purposely dilute the bottomline, NONE!
 






Anonymous said:
There is no "THEY", they are "US". There is no conspiracy, PRIMARY CARE got devastated ONLY because Taspoglutide got pulled, and Boniva is in a market that is almost 80% generic, and is going off patent next April. The bottomline is that based on the market conditions, there should have been a big cut years ago. The anticipation of Taspo is all that prevented this. For example, for two years MCR reps were carried when they really had no product to sell. They should have been fired 3 years ago. There are some great products in the pipeline, and if those products come to fruition, primary care will be expanded.

First off, I am Legacy PC. As far as george is concerned, he was offered a job in the new organization, and he decided not to accept it. Besides, he was not terminated by some "legacy" Genentech manager, he was fired by basel based executive management. As far as dick goes, he was highly ineffective. He was in charge of a franchise that was dramatically underperforming. If you loved him so much, you should have "sold" more boniva. The problem with Tim and George is that the were too squeamish too make critical BUSINESS decisions. I use the MCRs as one example, from a business perspective, ALL MCR positions should have been eliminated more than three years ago, yet they were kept. The fact that you had 7 regional offices, each with their own sales ops, etc was also highly inefficient. Lastly resource allocation among the regions was pretty stupid. For example, all budgets, samples, etc were pretty much divided evenly among the seven regions, even though the business opportunities were heavily concentrated among 2-3 regions. The resources shoiuld have been divided in proportion to where the business was. The fact that the sales force is doing so well, now, with 75% fewer reps in proof positive that the sales force was waaaay to large, and should have been slashed years ago. And if there is no new product to sell by the end of the year, it is perfectly rational, and fiduciarily responsible for management to fire the rest of PC.

As far as oncology goes, both legacy forces have lost people, and as far as rheum goes, well Actemra is a DOG! My suggestion is that you stop thinking of yourself as a victim, and look at the business side of decisons, instead of the "THEY DONT LIKE US" side. No company is going to make decisions that purposely dilute the bottomline, NONE!
Click to expand...



The bottom line is that you big pharma roche dolts don't fit in.
 


















Top Bottom
Back
Quote